Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Penttinen

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 8, 2013
Taking stock of the first 133 MERS coronavirus cases globally--Is the epidemic changing?P M Penttinen, K Kaasik-Aaslav, A Friaux, et al.
Journal of Inherited Metabolic Disease|May 20, 2005
Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry diseaseR J Kalliokoski, K K Kalliokoski, J Sundell, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1997
[A critically ill newborn and an unconscious, sweet-smelling young man]O J Heinonen, K Näntö-Salonen, M K Salo, et al.
European Urology|October 15, 2015
Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: An Open-label Phase 1 StudyChristophe Massard, Heidi M Penttinen, Egils Vjaters, et al.
Journal of Inherited Metabolic Disease|May 30, 2008
Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parametersJ W Koskenvuo, J J Hartiala, P Nuutila, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 5, 2020
Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patientsL Vehmanen, H Sievänen, P Kellokumpu-Lehtinen, et al.
Nutrition & Diabetes|April 28, 2015
Role of the endocannabinoid system in obesity induced by neuropeptide Y overexpression in noradrenergic neuronsL H Vähätalo, S T Ruohonen, S Mäkelä, et al.
Human Genetics|July 8, 1998
Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delayM Upadhyaya, M Ruggieri, J Maynard, et al.
Muscle & Nerve|March 1, 2005
Enrichment of the R77C alpha-sarcoglycan gene mutation in Finnish LGMD2D patientsP Hackman, V Juvonen, J Sarparanta, et al.
Journal of Inherited Metabolic Disease|April 8, 2006
The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry diseaseR J Kalliokoski, I Kantola, K K Kalliokoski, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 8, 2013
Taking stock of the first 133 MERS coronavirus cases globally--Is the epidemic changing?P M Penttinen, K Kaasik-Aaslav, A Friaux, et al.
Journal of Inherited Metabolic Disease|May 20, 2005
Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry diseaseR J Kalliokoski, K K Kalliokoski, J Sundell, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1997
[A critically ill newborn and an unconscious, sweet-smelling young man]O J Heinonen, K Näntö-Salonen, M K Salo, et al.
European Urology|October 15, 2015
Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: An Open-label Phase 1 StudyChristophe Massard, Heidi M Penttinen, Egils Vjaters, et al.
Journal of Inherited Metabolic Disease|May 30, 2008
Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parametersJ W Koskenvuo, J J Hartiala, P Nuutila, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 5, 2020
Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patientsL Vehmanen, H Sievänen, P Kellokumpu-Lehtinen, et al.
Nutrition & Diabetes|April 28, 2015
Role of the endocannabinoid system in obesity induced by neuropeptide Y overexpression in noradrenergic neuronsL H Vähätalo, S T Ruohonen, S Mäkelä, et al.
Human Genetics|July 8, 1998
Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delayM Upadhyaya, M Ruggieri, J Maynard, et al.
Muscle & Nerve|March 1, 2005
Enrichment of the R77C alpha-sarcoglycan gene mutation in Finnish LGMD2D patientsP Hackman, V Juvonen, J Sarparanta, et al.
Journal of Inherited Metabolic Disease|April 8, 2006
The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry diseaseR J Kalliokoski, I Kantola, K K Kalliokoski, et al.
Pageof 4